- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/433 - Thiadiazoles
Patent holdings for IPC class A61K 31/433
Total number of patents in this class: 1739
10-year publication summary
|
118
|
149
|
116
|
98
|
118
|
108
|
107
|
104
|
135
|
93
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4747 |
37 |
| The Regents of the University of California | 20790 |
18 |
| Merck Sharp & Dohme LLC | 3737 |
18 |
| Novartis AG | 10224 |
16 |
| Betagenon AB | 24 |
16 |
| Takeda Pharmaceutical Company Limited | 2713 |
15 |
| Universite de Montreal | 348 |
15 |
| Board of Regents, The University of Texas System | 6127 |
14 |
| Calithera Biosciences, Inc. | 38 |
12 |
| Proteostasis Therapeutics, Inc. | 69 |
12 |
| Apnimed, Inc. (Delaware) | 62 |
12 |
| Boehringer Ingelheim International GmbH | 4487 |
11 |
| The Trustees of the University of Pennsylvania | 4416 |
11 |
| Abbvie Inc. | 1823 |
11 |
| Ovid Therapeutics Inc | 179 |
11 |
| Shionogi & Co., Ltd. | 884 |
11 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3002 |
11 |
| The Wistar Institute of Anatomy and Biology | 482 |
11 |
| Calico Life Sciences LLC | 111 |
11 |
| Hoffmann-La Roche Inc. | 3804 |
10 |
| Other owners | 1456 |